Zoono CEO steps down as investors fume

Zoono CEO steps down as investors fume
Zoono anti-viral being sprayed in a Melbourne tram, May 2020 (Image: Getty)
Denise McNabb
After days of rumours on an Australian investor forum and a query from the ASX about the company’s yo-yo share price, Zoono founder Paul Hyslop stepped down as chief executive on Friday.Hyslop will remain on the board of the New Zealand-based manufacturer of a proprietary, long-life hand and surface sanitiser. His move follows a volatile period for the ASX-listed global antimicrobials company that he formed in 2007 and took public a decade later.Its share price has slumped from a high of A$3.29 in July 2020, when the first onset of t...

More Markets

NZ stocks take Wall Street lead to end down 1%
Markets Market Close

NZ stocks take Wall Street lead to end down 1%

The S&P/NZX 50 Index closed down 133.41 points or 0.98% at 13,464.46.

Jamie Gray 14 Nov 2025
Zoono says it knows no reason for share price surge, halt lifted
Markets

Zoono says it knows no reason for share price surge, halt lifted

A trading halt granted by the ASX to Australian-listed New Zealand antimicrobials manufacturer Zoono on Wednesday after a price query has been lifted after the company said it knew of no reason for its share price soaring.Its share price rose from 0.09c to 0.18c on volumes much h...

Denise McNabb 14 Nov 2025
Comvita deal fails, attention turns to capital raise
Primary Sector

Comvita deal fails, attention turns to capital raise

“It is your company, and ultimately, shareholders determine its future.”

Riley Kennedy 14 Nov 2025